EBITDA: Income before interest, taxes, depreciation and amortization.
MacroGenics, Inc. (MGNX) had EBITDA of $-67.32M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$149.50M |
|
$-74.62M |
|
$36.01M |
|
$113.49M |
|
$222.34M |
|
$-72.84M |
|
$-2.45M |
|
$-75.29M |
|
$-75.29M |
|
$-74.62M |
|
$-74.62M |
|
$-74.62M |
|
$-74.62M |
|
$-72.84M |
|
|
EBITDA |
$-67.32M |
63.16M |
|
63.16M |
|
$-1.18 |
|
$-1.18 |
|
| Balance Sheet Financials | |
$219.94M |
|
$12.62M |
|
$36.91M |
|
$256.85M |
|
$43.12M |
|
-- |
|
$158.14M |
|
$201.25M |
|
$55.59M |
|
$55.59M |
|
$55.59M |
|
63.32M |
|
| Cash Flow Statement Financials | |
$-81.04M |
|
$-114.10M |
|
$69.51M |
|
$182.84M |
|
$57.22M |
|
$-125.62M |
|
$14.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
75.91% |
|
-48.72% |
|
-48.72% |
|
-45.03% |
|
-50.36% |
|
-49.91% |
|
$-82.94M |
|
-- |
|
-- |
|
-- |
|
0.58 |
|
4.55 |
|
11.18 |
|
32.65 |
|
-134.23% |
|
-134.23% |
|
-29.05% |
|
-134.23% |
|
$0.88 |
|
$-1.31 |
|
$-1.28 |
|